Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The Quest for Oral GLP-1s In a recent survey, three-in-four respondents said they would prefer a oncedaily oral pill over a weekly injection of GLP-1s
Newer drugs such as tirzepatide (Mounjaro, Zepbound) target GLP1 and GIP (dual agonist)
Hydration is paramount when experiencing diarrhoea
Tirzepatide is a research compound sold for laboratory and research use only
If you see no meaningful results after 812 weeks, a clinical review may be needed If you experience severe or persistent side effects that do not improve If there are signs of hormonal or metabolic issues affecting progress If you need guidance on dose adjustment or treatment optimisation A clinician can assess your response, review your routine, and adjust your plan where necessary
Oral vs Injectable AOD 9604: Why the Form You Receive Matters Not all AOD 9604 is delivered the same way, and the form affects how reliably it can work
